Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06738030 · ClinicalTrials.gov registry record · NA
Transcranial Stimulation Combined With Auditory Training
A NA study, sponsored by Boston University Charles River Campus.
- Not yet
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT06738030: Clinical Trial NA study, sponsored by Boston University Charles River Campus.
NCT06738030 is a NA study that has not yet begun recruiting, run by Boston University Charles River Campus. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06738030, a NA study, has not yet begun recruiting, sponsored by Boston University Charles River Campus.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if non-invasive brain stimulation (called transcranial stimulation) can enhance the benefits from auditory training in people who struggle to understand one talker when many people are talking at the same time. The main questions it aims to answer are: * Does transcranial stimulation improve speech-on-speech understanding in people who struggle with this task? * Does transcranial stimulation enhance the benefits of a commercially available auditory training program? Researchers will compare transcranial stimulation to sham stimulation (no stimulation is applied during the listening task). Participants will: * Receive login information to an online auditory training program to complete at home over 2 weeks * Visit the laboratory 4 times to receive transcranial stimulation while listening to speech-on-speech: once before at-home training, two times during the at-home training period, and once after at-home training has ended
Primary Outcome
Percent correct score on the speech-on-speech task assessed in the lab
Interventions
- BEHAVIORAL Auditory training
- DEVICE Transcranial current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2026-08 |
| Phase | NA |
What is known before NCT06738030 opens enrollment
NCT06738030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Auditory training is the first listed.
NCT06738030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06738030 about?
NCT06738030 is a clinical study titled "Transcranial Stimulation Combined With Auditory Training". The goal of this clinical trial is to learn if non-invasive brain stimulation (called transcranial stimulation) can enhance the benefits from auditory training in people who struggle to understand one talker when many people are talking at the same time. The main questions it aims to answer are: * ...
What is the current status of trial NCT06738030?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2025-01-20. Estimated completion is 2026-08.
What interventions are being tested in trial NCT06738030?
The interventions under investigation include: Auditory training (BEHAVIORAL), Transcranial current stimulation (DEVICE).
Who is sponsoring clinical trial NCT06738030?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06738030's enrollment target sits among peer trials
94 935th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI